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Danai Chasioti
A Longitudinal Analysis for the identification of the factors that affect the Case Mix Index of
Hospitals in the U.S.
The present thesis is an analysis of longitudinal data collected through the years 2011-2013, from
a complex of four hospitals located in Indiana, USA. The aim of the analysis was the detection of
changes (especially a decline) in the disease related group (DRG) weights (and thus, the case mix
index (CMI)), and the determination of the predictors that significantly affect these changes.
The document is divided in four major parts. In the first part it is described the statistical theory
required for the the analysis, in the second part the reimbursement strategies for the hospitals in the
USA, are briefly described and the concept of the DRG and CMI are explained. In the third part
the actual analysis is presented while the last part contains a summary of the findings and some
conclusions.
The correlation between the observations was taken into account by modeling the data using linear
mixed models (LMM). Three major factors were studied for their effect on the DRG weight of the
hospitals: the changes in the type of cases (i.e. the product lines), the changes in the number of the
Surgical cases, and also the changes of the length of stay (LOS). The analysis did not indicate any
significant DRG change in any of the hospitals except from the H4. The H4 hospital has a significant
decline over time regarding the Cardio-vascular (CV) DRG weights. For the hospitals H1, H2 and
H3 the only decline observed in the product lines was that for the Medical-Surgical DRG. Finally,
no significant change was observed for the LOS, or the number of Surgical cases.
In addition to the three predictors studied, changes in the coding system, the documentation etc.
may also affect the DRG and CMI. However, these changes are not possible to be detected through
this analysis, since no available information was given in the present data.
Constantin T. Yiannoutsos
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Chapter 1
Theoretical Background
1.1 Linear Models for Continuous Longitudinal Data
1.1.1 Overview
In longitudinal studies, the investigators collect information about specific characteristics of a co-
hort over time. The observations are collected on individual level and may differ in number and
time point of collection.
Let Yi j be the response variable for the individual i at the jth time measurement . To accommodate
unbalanced measurements, we assume that each individual i has ni observed responses. Let N the
total number of the individuals in the study. For each of these individuals there is an ni× 1 corre-
sponding vector of responses
Yi =

Yi1
Yi2
...
Yini

, i= 1, . . . ,N
where, Yi1, . . . ,Yini are dependent to each other (within-individual association). At each measure-
ment occasion j, the values of the (p) covariates Xi jl (l = 1, . . . , p) are measured. Thus, to each
individual i corresponds a design matrix Xi with dimensions ni×p
Xi =

X ′i1
X ′i2
...
X ′ini

⇔ Xi =

Xi11 . . . Xi1p
Xi21 . . . Xi2p
... . . .
...
Xini1 . . . Xinip

, i= 1, . . . ,N
Each of the Yi j responses is described by a linear regression model :
Yi = Xiβ + ei where, (1.1)
1
Yi the ni×1 matrix of responses, Xi the ni× p matrix of covariates, β the p×1 vector of regression
coefficients and ei the ni× 1 vector of the random errors (that is, the ei j is the deviation of the
predicted E(Yi j|Xi j) from the observed Yi j response).
Yi = Xiβ︸︷︷︸
Systematic part
+ ei︸︷︷︸
Random part
where,
the vector Yi follows a Multivariate Normal distribution with mean E(Yi) = µi = Xiβ and covariance
matrixCov(Yi)=Σi. Each of the elementsYi j ∼N(µi j,σ2j ). The within-subject association, between
the repeated measurements of each individual, is expressed by the off-diagonal elements of the
covariance matrix Σi =Cov(Yi).
In order to properly take into account the within-subject association of the repeated measurements,
we need not only to model the mean response but also the covariance. Bellow it is presented a brief
presentation of the alternative ways used to model the covariance (See Figure 1.1).
To model the repeated measurements’ covariance, we can either assume specific pattern for the
covariance matrix (covariance pattern models) or allow the covariance to vary randomly over time
(unstructured covariance). In both of these cases, the mean and the variance are modeled separately
(but not independently). Finally, we can account for the correlation by assuming a covariance pattern
in the same model used to model the mean responses (the random effects in the mixed models induce
association between the responses).
Modeling the covariance
Unstructured Covariance Covariance Pattern ModelsRandom Effects Co-
variance Structures
Figure 1.1: Modeling the Covariance
By correctly determine the within-subject covariance pattern and by assuming a model for the mean
response, we can get accurate estimates of the regression parameters . When the investigator’s goal
is the interpretation of the findings on population’s level then, the mean response can be modeled
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using either the response profiles or the parametric/semi-parametric curves methods (See Figure
1.2).
Modeling the
mean response
Profile Analysis
(Balanced data required) Parametric Curves
Figure 1.2: Modeling the Mean response
When the measurements have been taken at common time points for each individual in the study
(the design is balanced), and the number of the measurements is small, the profile analysis can be
used to describe the mean changes of the response over time. A general form of the response profile
model is presented below:
Yi = Xiβ + ei where, (1.2)
Xi is a j× k design matrix (for the subject i) with j = 1, . . . ,m measurement occasions. The Xi can
be written as 
G1
G2
...
Gl

where,
G1,G2, . . . ,Gl are m×m square sub-matrices and l = 1, . . . ,n is the total number of groups. So, the
matrix Xi has in total k = l×m columns.
This type of analysis is indicated when the study design is balanced and the number of covariates is
small. The response profile analysis incorporates the time variable in its categorical form resulting
to a saturated model that over fits the data. Also, it uses more parameters for the mean change over
time than it is required (usually the changes over time are not sharp) and has less power to detect
departs from the null hypothesis. So, a more parsimonious model with higher power is desirable. An
alternative to the response profile analysis would be the use of parametric/semi-parametric models.
By assuming the correct mean response pattern over time, these models have greater power to test
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changes over time compared to the response profiles. In addition, the parametric models can handle
the unbalanced and incomplete data (which is common characteristic of the data in longitudinal
studies). Linear, quadratic, higher order trends and linear splines are used to describe the change
of mean response over time. In this case, time is treated as a continuous variable. Thus, a design
matrix Xi for a quadratic model and an exposed individual, could be the following:
Xi =

1 ti1 t2i1 1 1 t
2
i1
1 ti2 t2i2 1 1 t
2
i2
...
...
...
...
...
...
1 tini t
2
ini 1 1 t
2
ini

where, the fourth column is the group variable (1 for treatment/exposure and 0 for the unex-
posed/controls) and the last two columns represent the group× time interaction and the group×
time2 respectively. The number of the repeated measurements for the ith individuals is ni.
Given that the data on which the parametric/semi-parametric models are applied on, is usually un-
balanced, an unstructured covariance pattern would lead to an extremely high number of parameters
to estimate. That implies that, a more "conservative" pattern should be adopted in order to get valid
estimates for the regression parameters.
1.1.2 Linear Mixed Models
Whenever the goal of the investigator is to predict the individual trajectories, the use of mixed
models is indicated. In addition, the mixed effects models combine the advantages of the parametric
curve models, in terms of their ability to handle unbalanced data and be parsimonious (small number
of covariance parameters to be estimated).
A linear mixed effects model applies to longitudinal data where the response variable is continuous
and the residuals ei j follow a Normal distribution. The inference about an individual is becoming
possible since the model "breaks" the inherited variability into two parts: the population variability
and the individual variability (i.e. the between-subject and within-subject variability). In addition
to the ability to make individual-based predictions/inferences, the linear mixed effects models have
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the ability to model the covariance of the repeated measurements by incorporating one (or more)
random effects. A compound symmetry covariance pattern is introduced by including a random
intercept in the mixed model. A random intercept term is translated as an deviation of an individual’s
mean response from that of the population’s which, is constant over time. Such a model is expressed
by the following function:
Yi = Xiβ +Zibi+ ei where, (1.3)
Xi is an ni× p matrix of variables, β is a p× 1 vector of fixed-effect coefficients, Zi is the ni× q
design matrix of random effects (q≤ p) and bi the q×1 vector of random-effect coefficients while,
ei is an ni×1 vector of measurement/sample errors. Assuming independency between the random-
effect coefficients (bi) and the errors (that is, corr(bi,ei) = 0 ), we derive the following relation:
Cov(Yi j,Yik) =Cov(X ′i jβ +Z′i jbi+ ei j,X ′ikβ +Z
′
ikbi+ eik) =
=Cov(Z′i jbi+ ei j,Z
′
ikbi+ eik) = Zi jCov(bi,bi)Z
′
ik⇒
⇒Cov(Yi j,Yik) = Zi jGZ′ik where, (1.4)
G is an q×q square covariance matrix for the random-effect coefficients vector bi and, Zi j an ni×1
vector from the random effects design matrix for the individual i at the jth measurement occasion.
Specifically for a random intercept model, Zi is an ni×1 vector, bi is an 1×1 element and, G is an
1×1 element as well. Thus,
Cov(Yi j,Yik) = σ2b , ∀ j 6= k (1.5)
for the off-diagonal elements of the covariance matrix Cov(Yi) while, the diagonal elements of the
same matrix are:
Cov(Yi j,Yi j) =Cov(X ′i jβ +Z′i jbi+ ei j,X ′i jβ +Z′i jbi+ ei j) =
= Zi jCov(bi,bi)Z′i j+Cov(ei j,ei j)⇒
⇒Var(Yi j) = σ2b +σ2, j = 1, . . . ,ni (1.6)
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That is,
Var(Yi) =

σ2b +σ
2 σ2b . . . σ
2
b
σ2b σ
2
b +σ
2 σ2b σ
2
b
...
...
. . .
...
σ2b σ
2
b . . . σ
2
b +σ
2

(1.7)
Notice that, the random intercept model introduces a compound symmetry covariance pattern for
the data. A more general covariance pattern can be adopted by incorporating more than one random
effects in the model. In that case, the marginal covariance is:
Cov(Yi) =Cov(Xiβ +Zibi+ ei) = ZiCov(bi)Z′i+Cov(ei)
For Cov(bi) = G and Cov(ei) = Ri = σ2I we get,
Cov(Yi) = ZiGZ′i+Ri (1.8)
So, Yi ∼ N(Xiβ , ZiGZ′i + Ri), ei ∼ Nni(0,Ri), bi ∼ Nq(0,G) while the subject-specific response
Yi|bi ∼ N(X ′iβ +Z′ibi,Ri), Cov(Yi|bi) =Cov(ei) = Ri the conditional covariance and
E(Yi|bi) = E(Xiβ +Zibi+ ei) = Xiβ +Zibi (1.9)
which has an individual-based interpretation. In contrast, the population based inference uses the
marginal mean response
E(Yi) = Xiβ (1.10)
1.2 Generalized Linear Models for Discrete Longitudinal Data
1.2.1 Marginal Models
Frequently, the response of interest is a binary, count or even a continuous variable which, does not
fulfill the distribution assumption of normality. In order to handle such situations, the generalized
linear models (adequately modified to handle longitudinal data) are available. Again, there are
6
different models depending on whether it is of interest a population or an individual-based inference.
For the former case of population-based inferences, models which contain no random effects, known
as marginal models, can be used. The within-subject association of the responses is taken into
account by determining the correlation pattern Corr(Yi j,Yik) among the repeated measurements in
the case of continuous responses/counts and by determining the log(OR)[Yi j,Yik] for the case of
binary responses.
In contrast to the continuous response, the discrete responses (e.g., counts, binary outcome) have a
restrictive range which might not always coincide with that of the predictions’ Xiβ . To overcome
this issue, the marginal models, similarly to the GLMs, use link functions:
g(E(Yi j)) = g(µi j) = ηi j = X ′i jβ (1.11)
A link function maps the elements of the mean response’s range to the domain of the covariates.
1.2.2 Generalized Linear Mixed Models
While in the marginal models the association between the measurements is taken into account by
separately modeling the correlation (or the log(OR); depending on the nature of the response vari-
able), with the Generalized Linear Mixed Models (GLMMs), the introduction of random effects
induces the association.
In contrast to the marginal models which, do not require any distributional assumptions for es-
timating the parameters, for the GLMMs we need to specify the distribution of the outcome Yi j
conditioning on the random effects vector bi. The distribution for the vector of the random effects
is necessary as well. Similarly to the Generalized Linear Models (GLMs), we can use the same
idea to model continuous, binary or count data and similarly to Linear Mixed Models (LMMs), the
within-subject correlation is taking into account by the incorporation of the random effects in the
model. A general form of a GLMM is:
ηi j = E(Yi j|bi) = X ′i jβ +Z′i jbi where, (1.12)
ηi j is the link function. Since the estimation of the mean response is conditional on the subject-
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specific random effects, the interpretation is also subject-specific as opposed to the population-based
interpretation of the marginal models. Thus, the estimated coefficient of a fixed effect indicates the
average individual’s change of its transformed mean, given the values of the random variables at the
specific time point and for a unit change of the (time varying) variable Xill .
An exception to the above interpretation is the case of an identity link function ηi = 1 where, the
conditional mean response coincides with the interpretation of the population mean.
g(E(Yi j|Xi j,bi)) = ηi = E(Yi j|Xi j,bi) = E(X ′i jβ +Z′i jbi) = X ′i jβ (1.13)
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Chapter 2
Health Services in U.S.
Back in 1970, Yale university introduced a system for the classification of similar inpatient cases in
hospitals, known as the Disease Related Groups (DRGs) [1]. Each case is represented by one DRG
code based on the patient’s demographic information such as age and sex, as well as the primary
and secondary diagnosis, the possible co-morbidities, complications, surgery, other procedures per-
formed and discharge status [2], [6]. There are total 474 DRGs [3]. The DRG classification was
initially used by the private insurance systems while, in the early ’80s the U.S health system adopted
the idea of DRGs by, incorporating it in a DRG-based payment system, primarily by the Medicare
program (1983) [1], [3], [4]. An accurate use of the DRG system will help control the cost and
increase the resources’ efficiency.
Known as "case-based" or "case-mixed-case" [5], the DRG system is based on classification algo-
rithms in order to map each hospital case to one of the DRGs. There are totally 6 algorithms (called
groupers) for DRG classification two of which are not used any more (the CMS-DRG and the AP-
DRG) [3]. Cases belonging in the same DRG, are not only medically similar but also financially
[5]. Inter alia, the role of the DRG classification in the payment system is to provide an average
level of hospital resources required to treat a patient within a group. That is obtained by assigning
a relative weight to each of the DRGs. Consecutively, Medicare’s payment to the hospital is an
amount proportional to this relative weight. By that, it is implied that the DRG coding system can
affect the hospital’s payment through the DRG’s impact on the Case Mix Index (CMI) values (Table
2.1).
Table 2.1: Changes in DRG Case-Mix Indexes and in average DRG weight due
to documentation/code system improvements, 1981-1987 [2]
.
Actual change Percentage change
1981 1984 1985 1986 1987 1981-84 1984-85 1985-86 1986-87
Average CMI 1.00 1.06 1.09 1.11 1.13 5.93% 3.09% 2.04% 1.66%
Average case weight 1.05 1.13 1.18 1.21 1.24 7.73% 4.37% 2.88% 2.40%
Adjusted average
case weight
1.05 1.13 1.19 1.23 1.26 7.75% 5.52% 2.88% 2.39%
The CMI, which is directly related to the DRG weights, is a measure of the complexity of a hos-
pital’s cases. Developed in 1981, the CMI is the basis for payment methods, and it is calculated
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by averaging the DRG relative weights of a hospital, for each time period (e.g. month, quarter,
year etc.). There are five categories of CMI in total (Overall, Medical, Surgical, Adjusted, Med-
ical/Surgical mix and volume-adjusted CMI) [8]. Based on the definition of the Case Mix Index,
we can see that changes of its levels over time, affect the revenue stream of the hospital. Specifi-
cally, the higher the CMI level, the higher the reimbursements/revenue for that hospital since, a high
CMI level suggests a higher-weight DRG cases and thus, higher amount to receive per patient. The
DRG-based payment system depends on several factors that affect its accuracy and efficiency which
are not always easy to detect and control. Hence, the coding accuracy and documentation can have
a significant impact on the hospital’s revenue by declaring an over or under-estimated CMI level
(relative DRG-weight).
The intentionally false coding that indicates a higher than the real case complexity (and thus, a
higher reimbursement amount), is a weak point in the relation between the hospitals and the gov-
ernment. The improvement in the documentation system and the detection of other factors that
could possibly be responsible for the observed CMI (or DRG-weight) changes, could soothe the
hospital-government relation by revealing the truth behind the changes.
In addition to the technical reasons that could affect the CMI levels, such as coding and documenta-
tion, the change in mix of weights (that is change in the DRG weights), the decrease of the Length
Of Stay (LOS) as well as the technological and treatment improvements (less inpatient cases) can
also have an significant effect on the fiscal measures of a hospital. The emerge for the study of the
CMI changes emanate from the need to set fair payments as well as from to further discover how
the health system works.
The substitutions of the retrospective cost-based payment system by the DRG-based payment sys-
tem (PPS), gave rise to several incorrect coding incidences. A study held by David C. Hsia in 1988
[9], [10], shows that for the time period of October 1984 to March 1985, the chance that a hospi-
tal will inaccurately classify a case was 20.8%. It is noteworthy that, while the case-based system
would most probably lead to a hospital’s underpayment in case of coding errors, under the PPS,
61.7% of the coding errors would favor the hospital towards an over-payment. The changes in CMI
(especially when they are upward) need to be controlled and restricted when, they are the result
of intentional (or unintentional) errors. The source of false CMI change, based on a sample of the
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1986-1987 Medicare discharged data, is 33.3% [11] of the total change for that time period. From
that 33.3%, 85% [11] was due to hospitals’ incorrect coding, 0.7% [11] of the CMI’s divergence can
be attributed to the sensitivity differences between the several Groupers. A direct consequence of
the over-coding is the effect on the level of hospital’s CMI and thus, the amount of reimbursement.
The importance of controlling such incidence can be explained by the fact that, the expenditure
resulted for 1% increase of the CMI level is equivalent to $40 million for the government [11].
Based on the results of a study that compared the pre-PPS to the post-PPS period, it has been ob-
served a decrease of the LOS by 24% (95% CI: (3.1, 3.8)) [12], which did not affect the quality of
services though [13]. The PPS it also does not seem to affect [14] the rising quality of the in-hospital
services. On the other hand, data of the period July 1985 to June 1986 (post-PPS period) indicates
an increase of the number of patients which had been discharged at home in a non-stable condition
[15]. A follow up study on data selected during the years 1983-1992 [16], indicates that people
of age 65 or older have three times higher risk of re-admission, 2 months after their discharge. A
different study, showed more specifically that, 180 days after the admission, the number of read-
mission does not differ for the periods 1981-1982 (pre-PPS) and 1985-1986 (post-PPS) (there was
1% decrease, p-value > 0.05). In contrast, the respective number, one year after the admission, had
been significantly decreased (p-value< 0.05).
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Chapter 3
Analysis
The goal of this work is the investigation of the CMI changes of a network of hospitals in the
state of Indiana, and the factors that could have possibly affect the CMI levels. The data contains
information collected during the period 2011-2013.
An overview of the data is given in Figure 3.1, which describes the levels of DRG-weights over time
for each of the hospitals. Notice the big difference of the DRG-weight levels between the hospital
H4 and the rest of the hospitals. That was expected since H4 is a hospital mainly specialized to a
specific disease (90.3% of its cases) with high surgery needs (70.54% among the specific disease’s
cases). The rest three hospitals though, seem to be very similar in terms of their DRG-weight levels.
The variation over time looks constant for all four hospitals. However, these are just observations
based on the graph given below (Figure 3.1: subfigure 3.1.1).
Subfigure 3.1.1: Median DRG weight
over time for all hospitals
Subfigure 3.1.2: Median DRG weight
over time for H1, H2 and H3 hospitals
Subfigure 3.1.3: Median DRG weight
over time for the H4 hospital
Figure 3.1: Median DRG weight over time for the hospitals.
By taking a closer look on the DRG-weight plots (Figure 3.1: subfigure 3.1.2, subfigure 3.1.3) it
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seems that, the H4 hospital has a slightly rising DRG-weight over time while, the DRG-weight for
the rest of the hospitals is declining.
Since the nature of the data requires the application of Linear Mixed Models (LMM), we have to
check some of the assumptions that need to be met. Because the normality assumption of the the
outcome variable is violated (Figure 3.2.1), we apply the Box-Cox transformation (t(y) = (yλ −
1)/λ ;λ = −0.5; see Figure 3.2.2). Thus, instead of modeling the DRG weight, we are modeling
a function of this quantity, and as we will se latter, we use the inverse quadratic root to model the
length of hospitalization (LOS). Using a random intercept and slope LMM, we get that the marginal
mean of the transformed DRG weight for the H3 hospital is the second largest, following the H4
which is used as reference hospital for comparisons, followed by the H1 and H2 hospitals (See Table
3.1, Model M1).
Figure 3.2.1: DRG weight
Figure 3.2.2: Box-Cox transformation
of DRG weight
Table 3.1: Regression of the hospital factor on the transformed DRG weight, using LMM.
Model M1 1: E[g(DRG)i j] = b0i+β0+b1iHospital+
+β1H1i j+β2H2i j+β3H3i j+β4Timei j
Model M1
Hospital Estimate Std.error 95%CI p-value
Intercept 0.345 0.026 (0.293, 0.398) < 0.0001
H1 -0.238 0.027 (-0.292, -0.185) < 0.0001
H2 -0.259 0.026 (-0.311, -0.208) < 0.0001
H3 -0.169 0.028 (-0.225,-0.113) < 0.0001
From the same model (Model M1) we also get that, the levels of the DRG weight for each of the
H1, H2, H3 hospitals are significantly different from these of the baseline category (i.e. the H4 hos-
pital) (p-value< 0.0001 for all of the hospitals, see Table 3.1, Model M1). A statistically significant
1 Box-Cox transformation: g(y) = y
λ−1
λ , where λ =−0.5
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rate difference is also observed (interaction of the each of the three hospitals with the Time; See
Table 3.2, Model M2) between each of the hospitals and the hospital H4. Specifically, the mean
DRG weight for the general hospitals (H1, H2, H3) significantly differs, over time, from that of the
H4 hospital (see Table 3.2, Model M2; interaction terms). These hospitals have a declining DRG
weight over time (see Table 3.2, additional estimations) however, this reduction is not big enough
to be considered as statistically significant (see Table 3.2; additional estimations: p-value>0.05 for
all three hospitals).
Finally, the negative coefficient of the time variable expresses a statistically significant declining
rate for the DRG weight of the H4 hospital (See Table 3.2, Model M2; p-value< 0.0001). That is,
among the cases in the H4 hospital, the mean DRG weight is declining over time and that decline is
statistically significant (See Table 3.2, Model M2, time coefficient; See Figure 3.3).
Table 3.2: Regression of the hospital factor, the time variable
and their interaction on the transformed DRG weight, using LMM.
Model M2: E[g(DRG)i j] = b0i+b1iHospital+β0+β1H1i j+β2H2i j+
+β3H3i j+β4Timei j+β5(TimeH1)i j+β6(TimeH2)i j+β7(TimeH3)i j
Model M2
Variable Estimate Std.error 95%CI p-value
Intercept 0.3725 0.0276 (0.3182, 0.4268) < 0.0001
H1 -0.258 0.015 (-0.3139, -0.2021) < 0.0001
H2 -0.2855 0.0146 (-0.3398, -0.2312) < 0.0001
H3 -0.1963 0.0161 (-0.2551, -0.1374) < 0.0001
Time(Quarters) -0.0058 0.00157 (-0.0089, -0.0028) 0.0002
Time*H1 0.00422 0.00189 (0.00049, 0.0079) 0.0264
Time*H2 0.00561 0.0018 (0.002, 0.0092) 0.0021
Time*H3 0.00575 0.002 (0.0016, 0.0098) 0.0057
Additional estimations
Varible Estimate Std.error 95%CI p-value
β4+β5 -0.00166 0.001 (-0.00376, 0.00044) 0.12
β4+β6 -0.00027 0.0009 (-0.0021, 0.00155 ) 0.76
β4+β7 -0.00013 0.0013 (-0.0028, 0.00254) 0.92
Figure 3.3: Observed vs. estimated DRG
weight over time (Model M2)
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After applying a linear mixed model to analyze the data that excludes H4 (See Table 3.3; Model
M2.1; See Figure 3.4) we observe that, there is no significant reduction for the H3 hospital (H3
used as reference category) over time, in terms of its mean DRG weight (See Table 3.3, time coeffi-
cient; see Figure 3.4). Also, both H2 and H1 hospitals have significantly lower DRG weight levels
(at the baseline) compared to the H3 hospital (See Table 3.3- Model M2.1; p-value=0.0006 and p-
value=0.022 respectively) while, their DRG-weight rate is not significantly different (see Table 3.3,
interaction terms are not statistically significant) from that of the H3 hospital.
Table 3.3: Regression of the hospital factor, the time variable and their
interaction on the transformed DRG weight, using LMM (H4 excluded).
Model M2.1: E[g(DRG)i j] = b0i+b1iHospital+β0+β1H1i j+
+β2H2i j+β3Timei j+β4(TimeH1)i j+β5(TimeH2)i j
Model M2.1
Variable Estimate Std.error 95%CI p-value
Intercept 0.1692 0.018 (0.132,0.206) < 0.0001
H1 -0.0542 0.0235 (-0.1, -0.008) 0.022
H2 -0.0795 0.0227 (-0.1244, -0.0346) 0.0006
Time(Quarters) -0.00019 0.00133 (-0.0028, 0.0024) 0.889
Time*H1 -0.0015 0.00169 (-0.0048, 0.00186) 0.3743
Time*H2 -0.00011 0.0016 (-0.0032, 0.003) 0.9479
Figure 3.4: Observed vs. estimated DRG
weight over time (Model M2.1; H4 excluded)
Below are presented some candidate factors that could have affected the trend of the hospitals’ DRG
weight over time:
1. Change of the type of cases (i.e. change of the product lines)
Given that the different product lines have different DRG weights over time (Figure 3.5), a
change of the type of cases administered in the hospitals could cause a change on the overall
DRG weight. Based on the graph (Figure 3.5), although it looks that there are significant
differences between the mean DRG weight of the product lines, it is not clear whether there
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is significant change over time (i.e. whether there is an effect of time on the product lines).
Using the product line called "Women and Children" as the reference category we get that, the
"Spine" product line is the one with the highest DRG weight followed by the "Orthopedics"
and the "Cardiovascular" (see Figure 3.5). All of the product lines have significantly higher
DRG weight levels than the baseline (Women and Children product line) at time zero (See
Table 3.4,-Model M.3; see Figure 3.5), which seems to remain stable over time (the estimated
coefficient of the time variable has p-value=0.0825, see Table 3.4,-Model M3).
Figure 3.5: Mean DRG weight
over time per product line
Table 3.4: Regression of the Product-line factor, the time variable and their
interaction on the transformed DRG weight, using LMM.
Model M3: E[g(DRG)i j]) = b0i+b1iHospital+β0+β1Cardioi j+
+β2MedSuri j+β3Neuroi j+β4Oncologyi j+β5Orthoi j+β6Spinei j+
β7Timei j+β8(Cardio∗Time)i j+β9(MedSur ∗Time)i j+β10(Neuro∗Time)i j+
+β11(Oncology∗Time)i j+β12(Ortho∗Time)i j+β13(Spine∗Time)i j
Model M3
Variable Estimate Std.error 95%CI p-value
Intercept -0.27 0.023 (-0.318, -0.226) < 0.0001
Cardiovascular 0.479 0.023 (0.433, 0.526) < 0.0001
Medical-Surgical 0.434 0.0229 (0.389, 0.478) < 0.0001
Neurology 0.489 0.0255 (0.439, 0.538) < 0.0001
Oncology 0.504 0.0279 (0.45, 0.55) < 0.0001
Orthopedics 0.637 0.026 (0.586, 0.688) < 0.0001
Spine 0.6906 0.029 (0.634, 0.747) < 0.0001
Time(Quarters) 0.0052 0.003 (-0.00067, 0.0111) 0.0825
Cardiovascular*Time -0.0095 0.0032 (-0.0158, -0.0032) 0.0032
Medical-Surgical*Time -0.00714 0.0031 (-0.013, -0.001) 0.0219
Neurology*Time -0.00616 0.0035 (-0.013, 0.0008) 0.0825
Oncology*Time -0.00163 0.0042 (-0.009, 0.0065) 0.6973
Orthopedics*Time -0.0032 0.0034 (-0.01, 0.0036) 0.359
Spine*Time -0.00355 0.004 (-0.011, 0.004) 0.383
Additional estimations
Varible Estimate Std.error 95%CI p-value
β7+β8 -0.00427 0.0011 (-0.00647, -0.00207) 0.0001
β7+β9 -0.00191 0.0008 (-0.00351, -0.00031) 0.019
β7+β10 -0.00093 0.0018 (-0.0046, 0.0027) 0.06203
β7+β12 0.00167 0.0027 (-0.0037, 0.007) 0.5414
Type 3 test of Fixed effects
Varible X2 p-value
Productline 782.78 < 0.0001
Time*Productline 19.96 0.0028
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A significantly different rate of change, compared to Women and Children, is indicated for the
"Cardiovascular" and the "Medical-Surgical" product lines, over time (See Table 3.4-Model
M3, the estimated coefficient of the corresponding interaction effects have p-value=0.0032
and p-value=0.0219 respectively). Specifically (See Table 3.4, Model M3; additional estima-
tions), the Cardiovascular product line of the network has a significant declining trend over
time and that also holds for the Medical-Surgical product line, although the slope is not as
steep as for the Cardiovascular.
Due to the high percentage of Cardiovascular cases2 in the H4 hospital (H4 had 6,701 cases
while, the combined number of cases of other hospitals was 7,628) and because it has the
highest average Cardio-DRG weight, we analyze the product lines’ DRG weight for the rest
of the hospitals separately, excluding the cases belonging to the H4, in order to see how that
affects the DRG weights change of the other hospitals (See Table 3.5-Model M3.1.1).
The Medical-Surgical DRG weight still shows a significantly different rate of change over
time (Table 3.5- Model M3.1.1; p-value=0.0136) compared to the baseline rate of change
whereas, there is a marginally significant difference of the rate of change for the Cardiovas-
cular DRG weight, when it is compared to the baseline rate (See Table 3.5- Model M3.1.1;
p-value=0.0726). Specifically, the DRG weight for Cardiovascular product-line, shows a
slight reduction over time which is not statistically significant (See Table 3.5-Model M3.1.1;
additional estimations: p-value=0.693).
That is, the significant estimation of the Cardiovascular product-line by time interaction, pre-
sented by the Model 3 (See Table 3.4), must be either due to a significant rate of change of the
H4 DRG weight or due to an increased power of the Model 3 (compared to the M3.1.1 model
where, the H4 data has been excluded). On the other hand the Medical-Surgical product line
indicates a statistically significant reduction, in terms of its DRG weight, over time (See Table
3.5, Model M3.1.1; additional estimations (coefficient β7+β9)).
Based on the results of the model M3.1.2 (See Table 3.6; see Figure 3.6), the Cardiovascu-
lar DRG weight of the H4 hospital, shows a statistically significant decline over time com-
2 Also, the H4 hospital has the highest Medical-Surgical DRG weight, although the highest
percentage of Medical-Surgical cases is obtained for the H2 hospital.
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Table 3.5: Regression of the Product-line factor, the time variable and their
interaction on the transformed DRG weight, using LMM (H4 excluded).
Model M3.1.1: E[g(DRG)i j] = b0i+b1iHospital+β0+β1Cardioi j+β2MedSuri j+
+β3Neuroi j+β4Oncologyi j+β5Orthoi j+β6Spinei j+β7Timei j+
+β8(Cardio∗Time)i j+β9(MedSur ∗Time)i j+β10(Neuro∗Time)i j+
+β11(Oncology∗Time)i j+β12(Ortho∗Time)i j+β13(Spine∗Time)i j
Model M3.1.1
Variable Estimate Std.error 95%CI p-value
Intercept -0.28 0.02 (-0.32, -0.24) < 0.0001
Cardiovascular 0.427 0.024 (0.38, 0.47) < 0.0001
Medical-Surgical 0.4325 0.022 (0.38, 0.47) < 0.0001
Neurology 0.487 0.025 (0.43, 0.53) < 0.0001
Oncology 0.511 0.027 (0.45, 0.56) < 0.0001
Orthopedics 0.631 0.0256 (0.58, 0.68) < 0.0001
Spine 0.6935 0.028 (0.63, 0.75) < 0.0001
Time(Quarters) 0.0052 0.0029 (-0.0007, 0.011) 0.077
Cardiovascular*Time -0.0058 0.00331 (-0.012, 0.0005) 0.0726
Medical-Surgical*Time -0.0075 0.003 (-0.013, -0.005) 0.0136
Neurology*Time -0.0065 0.00347 (-0.013, 0.0003) 0.0604
Oncology*Time -0.0025 0.004 (-0.01, 0.005) 0.5449
Orthopedics*Time -0.0032 0.0034 (-0.009, 0.003) 0.3457
Spine*Time -0.0037 0.004 (-0.011, 0.0042) 0.365
Additional estimations
Varible Estimate Std.error 95%CI p-value
β7+β8 -0.0006 0.0015 (-0.00356, 0.00237) 0.693
β7+β9 -0.00214 0.0008 (-0.00388, -0.00073) 0.0075
Type 3 test of Fixed effects
Varible X2 p-value
Productline 803.94 < 0.0001
Time*Productline 13.59 0.0346
pared to the rest of the hospitals (see Table 3.6-Model M3.1.2; additional estimations; p-
value< 0.0001), while a significant increase of the Medical-surgical DRG weight is observed
for the H4 (See Table 3.7-Model M3.1.3; additional estimation, and Figure 3.7). Further-
more, one can notice that there is an opposite slope indicated by the observed and predicted
Cardiovascular-DRG weight for the general hospitals (see Figure 3.6). That difference can
be explained by the fact that the observed median presented in the Figure 3.6 doesn’t take
into account the correlation between the observations but in contrary, the predictions take the
correlation into account by introducing the random effects in the mixed model.
Figure 3.6: Observed vs. estimated
Cardio-DRG weight of the hospital H4
vs. other hospitals (Model M3.1.2)
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Table 3.6: Regression of the time variable on the transformed
Cardiovascular-DRG weight, using LMM.
Model M3.1.2: E[g(DRG)i j] = b0i+b1iHospital+β0+
+β1Cardioi j+β2Timei j+β3(CardioTime)i j+β4H4i j+
+β5(TimeH4)i j+β6(CardioH4)i j+β7(CardioTimeH4)i j
Model M3.1.2
Variable Estimate Std.error 95%CI p-value
Intercept 0.132 0.0136 (0.106, 0.159) < 0.0001
Cardio -0.019 0.0104 (-0.0403, 0.00048) 0.0556
Time(Quarters) -0.00086 0.0006 (-0.002, 0.00044) 0.197
Cardio*Time 0.00078 0.0016 (-0.002, 0.004) 0.638
H4 0.019 0.036 (-0.0504, 0.0904) 0.578
Time*H4 0.0102 0.005 (0.0003, 0.02) 0.0427
Cardio*H4 0.267 0.029 (0.2095,0.3252) < 0.0001
Cardio*Time*H4 -0.0177 0.0055 (-0.028,-0.007) 0.0012
Additional estimations
Varible Estimate Std.error 95%CI p-value
β2+β3+β5+β7 -0.00758 0.0016 (-0.0108, -0.00436) < 0.0001
Summarizing the observations made up to this point, it might be the decline of the Cardio-
vascular product line of the H4 hospital that significantly affects the overall (H1, H2, H3
and H4) DRG weight. That could be justified by the fact that, the significantly higher Car-
diovascular DRG weight (compared to the rest of the hospitals -see Table 3.6 Model 3.1.2;
Cardio*H4 coefficient) of the H4 hospital, shows a significant decline over time (see Table
3.6, Model M3.1.2; additional estimation). In contrary, the Medical-Surgical DRG weight
of the H4 is significantly lower compared to the other hospitals (see Table 3.7, Model 3.1.3;
Medical-Surgical*H4 coefficient).
Table 3.7: Regression of the time variable on the transformed
Medical-Surgical-DRG weight, using LMM (H4 excluded)
Model 3.1.3: E[g(DRG)i j] = b0i+b1iHospital+β0+β1MedSuri j+
+β2Timei j+β3(MedSurTime)i j+β4H4i j+β5(TimeH4)i j+
+β6(MedSurH4)i j+β7(MedSurTimeH4)i j
Model M3.1.3
Variable Estimate Std.error 95%CI p-value
Intercept 0.15 0.014 (0.12, 0.17) < 0.0001
Medical-Surgical -0.036 0.0074 (-0.051, -0.022) < 0.0001
Time(Quarters) 0.0008 0.0008 (-0.0009, 0.0025) 0.36
Medical-Surgical*Time -0.0029 0.0011 (-0.005, -0.00068) 0.011
H4 0.27 0.026 (0.22,0.32) < 0.0001
Time*H4 -0.0081 0.0018 (-0.0117, -0.00451) < 0.0001
Medical-Surgical *H4 -0.24 0.0317 (-0.303,-0.18) < 0.0001
Medical-Surgical *Time*H4 0.0216 0.006 (0.009,0.0333) 0.0003
Additional estimations
Varible Estimate Std.error 95%CI p-value
β2+β3+β5+β7 0.0114 0.0056 (0.000315, 0.02247) 0.0438
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Figure 3.7: Observed vs. estimated
Med-DRG weight of the hospital H4
vs. other hospitals (Model M3.1.3)
2. Change in the number of Surgical cases
Another hypothesis that we need to study when trying to explain the hospitals’ CMI change
(and as a result, DRG weight change), is that of the different DRG weights between the
Surgical and Medical type of cases.
From the Figure 3.8 we observe a big difference between the DRG weight of these two types
of cases. Indeed, by applying a LMM for the overall mean DRG weight (i.e. the mean DRG
weight without distinguishing among hospitals) we observe that the mean DRG weight of
the Medical cases is significantly lower compared to the Surgical cases (See Table 3.8-Model
M4; p-value< 0.0001). Also, the rate of change over time is significantly different for the two
DRG types (see Table 3.8, Model M4, interaction term with p-value=0.035).
Figure 3.8: Comparison of Medical
vs. Surgical cases’ median DRG weight
Taking a closer look on the change of the surgical cases within each of the hospitals (see
Figure 3.9), looks like all hospitals except from the H1, retain a steady percentage of Surgical
type of DRG over time. Compared to the H4, which has the highest percentage of surgical
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Table 3.8: Regression of the DRG type (Surgical vs. Medical) on the
transformed DRG weight, for all hospitals, using LMM.
Model 4: E[g(DRG)i j] = b0i+b1iHospital+β0+
+β1Medicali j+β2Timei j+β3(MedicalTime)i j
Model M4
Variable Estimate Std.error 95%CI p-value
Intercept 0.6 0.012 (0.57, 0.62) < 0.0001
Medical -0.73 0.006 (-0.745, -0.721) < 0.0001
Time (Quarters) 0.00024 0.0007 (-0.0012, 0.0017) 0.75
Medical*Time -0.00196 0.0009 (-0.0038, -0.00014) 0.035
Additional estimations
Varible Estimate Std.error 95%CI p-value
β2+β3 -0.00172 0.0058 (-0.00287, -0.00057) 0.0034
DRG type among its cases (that is, 68.25% while the H3 and H2 have 35.33% and 33.12%
respectively), the hospitals H1, H2 and H3 have significantly lower percentage of Surgical
cases at the baseline (See Table 3.9, Model M.5, p-value< 0.0001 for the H1, H2 and H3). In
addition, the odds of Surgical type of DRG for the H1 hospital differ significantly (see Table
3.9; interaction term time by H1, p-value=0.0419) from these of the H4 hospital (specifically
there is a decline- see Table 3.9, Model M5; additional estimations) while, its percentage of
surgical cases is the lowest compared to the other hospitals and differs significantly form that
of the H4 (see Table 3.9).
Overall, there have not been observed significant changes, in terms of the DRG type (i.e.
Medical or Surgical), that could have affected the mean DRG weight of the network, over
time (only the H1 hospital shows a change but this hospital does not have significant changes
of its DRG weight).
Figure 3.9: Observed vs. fitted probabilities
of surgical type of cases, for each hospital
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Table 3.9: Logistic regression (GLMM) of the DRG type (Surgical vs. Medical)
over the time and hospital variables. Independent correlation matrix.
Model M5: log[Pr[g(DRGtype)i j=1]Pr[g(DRGtype)i j=0] ] = β0+β1H1i j+
+β2H2i j++β3(H3)i j+β4Timei j+
+β5(TimeH1)i j+β6(TimeH2)i j+β7(TimeH3)i j
Model M5
Variable Estimate Std.error 95%CI p-value
Intercept 0.622 0.1517 (0.325, 0.9196) < 0.0001
H1 -1.785 0.2773 (-2.33, -1.24) < 0.0001
H2 -1.342 0.264 (-1.86, -0.82) < 0.0001
H3 -1.169 0.2534 (-1.66, -0.67) < 0.0001
Time (Quarters) 0.0116 0.0128 (-0.013, 0.036) 0.362
Time*H1 -0.041 0.02 (-0.08, -0.0015) 0.0419
Time*H2 -0.0081 0.0194 (-0.046, 0.03) 0.674
Time*H3 -0.0237 0.0342 (-0.091, 0.043) 0.4897
Additional estimations
Variable Estimate Std.error 95%CI p-value
β4+β5 -0.0294 0.015 (-0.059,0.000) 0.0504
β4+β6 -0.0035 0.0144 (-0.032, 0.025) 0.8085
β4+β7 -0.012 0.0319 (-0.074, 0.051) 0.7058
3. Change of the LOS
Another factor that could potentially affect the CMI of a hospital is the change in the LOS.
An increase on the number of short-stay cases (defined as ≤2 days hospitalization) in the
hospital can be a reason for the CMI’s decline. Based on the given data, when the length of
hospitalization is increased by one day, the mean DRG weight is increased as well and, this
effect is statistically significant (see Table 3.10, model M.6, p-value< 0.0001).
Table 3.10: Regression of the LOS(in days) on the transformed DRG
weight for all hospitals, using LMM
Model M6: E[g(DRG)i j] = b0i+b1iHospital+β0+β1LOSi j
Model M6
Variable Estimate Std.error 95%CI p-value
Intercept -0.0168 0.013 (-0.042, 0.009) 0.202
LOS (Days) 0.0394 0.00037 (0.038,0.04) < 0.0001
The LOS depends significantly on the time period we refer to (over time, the LOS is in general
increased; See Table 3.11-Model M7, p-value< 0.0001, see Figure 3.10), the hospital (See
Table 3.12-Model M8; see Figure 3.12) and the specific product-line 3 (see Figure 3.11 and
Table 3.15).
3 The lowest is LOS for Women and Children and the highest LOS is for oncology; mean=3.47
days, median=2 days and mean=5.13 days, median=4 days respectively
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Table 3.11: Regression of the Time variable over the transformed
LOS (in days),using LMM.˙
Model M74: E[g(LOS)i j] = b0i+b1iHospital+β0+β1Timei j
Model M7
Variable Estimate Std.error 95%CI p-value
Intercept 0.856 0.011 (0.835, 0.878) < 0.0001
Time (Quarters) 0.0078 0.00074 (0.006, 0.009) < 0.0001
Figure 3.10: Overall LOS (in days).
All hospitals included.
Figure 3.11: Overall LOS (in days).
All hospitals included.
Figure 3.12: Median LOS (in days)
by hospital
The hospitals H3 and H4 have the lowest mean LOS (3.91 and 3.99 days respectively while,
the hospital H2 has the highest mean LOS: 4.49 days). The mean LOS is not significantly
different among the H3 and H4 hospitals (see Table 3.12-Model M8, p-value=0.075). For the
rest of the hospitals (i.e. the H1 and H2), the LOS is significantly higher at the baseline (see
Table 3.12-Model M8, both of the p-values< 0.05).
Over time, all of the hospitals indicate a statistically very significant increase of the LOS (see
Table 3.14, Model M10). In terms of CMI (and thus DRG weight), we would expect that this
implies an increase of the hospitals’ DRG weight as well. Indeed, for the short stay cases
4 Box-Cox transformation: g(y) = y
λ−1
λ , where λ =−0.25
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(defined as hospitalization for at most two days), the mean DRG weight is significantly lower
compared to cases who needed longer hospitalization (see Table 3.13-Model M9).
Table 3.12: Regression of the Hospital and Time variable on the
transformed LOS (in days), using LMM.
Model M8: E[g(DRG)i j] = b0i+b1iHospital+β0+β1H1i j+
+β2H2+β3H4+β4Timei j
Model M8
Variable Estimate Std.error 95%CI p-value
Intercept 0.83 0.0146 (0.8, 0.86) < 0.0001
H1 0.046 0.022 (0.033,0.09) 0.034
H2 0.049 0.02 (0.0089, 0.09) 0.017
H4 -0.0535 0.029 (-0.1125, 0.0055) 0.075
Time (Quarters) 0.0077 0.00074 (0.006, 0.009) < 0.0001
Type 3 test of Fixed effects
Varible X2 p-value
Hospitals 5.34 0.0001
Table 3.13: Regression of the short stay cases (i.e LOS(≤ 2days))
on the transformed DRG weight, using LMM.
Model M9: E[g(DRG)i j] = b0i+b1iHospital+β0+β1LOSi j
Model M9
Variable Estimate Std.error 95%CI p-value
Intercept 0.246 0.0127 (0.22, 0.271 ) < 0.0001
LOS(≤ 2days) -0.245 0.0033 (-0.252, -0.239) < 0.0001
Table 3.14: Regression of the Hospital and Time variable on
the transformed LOS (in days), using LMM (interaction term included).
Model M10: E[g(LOSi j)] = b0i+ b1iHospital+β0+β1H1i j+β2H2i j+
+β3H3i j+β4Timei j+β5(TimeH1)i j+β6(TimeH2)i j+β7(TimeH3)i j
Model M10
Variable Estimate Std.error 95%CI p-value
Intercept 0.76 0.028 (0.7, 0.817) < 0.0001
H1 0.128 0.032 (0.066, 0.19) < 0.0001
H2 0.124 0.0307 (0.064, 0.185) < 0.0001
H3 0.0707 0.032 (0.007, 0.134) < 0.0001
Time (Quarters) 0.012 0.002 (0.0082, 0.0161) < 0.0001
Time*H1 -0.006 0.0024 (0.011, -0.014) 0.011
Time*H2 -0.0047 0.0023 (-0.009, -0.00018) 0.042
Time*H3 -0.00423 0.0026 (-0.009, 0.0014) 0.15
Additional estimations
Varible Estimate Std.error 95%CI p-value
β4+β5 0.00596 0.0013 (0.0032, 0.00866) < 0.0001
β4+β6 0.0074 0.00118 (0.005, 0.0097) < 0.0001
β4+β7 0.00831 0.0017 (0.00492, 0.0117) < 0.0001
Type 3 test of Fixed effects
Varible X2 p-value
Hospitals 20.76 0.0001
Time*Hospitals 0.00831 0.0848
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Studying the change of the LOS for the product lines (see Table 3.15-Model M11), we see that
the Orthopedics as well as the Neurology have a significantly different rate of LOS change,
compared to the reference product line (p-values=0.003 and 0.038 respectively) while, no
significant difference on the LOS rate of change is observed for the rest of the product lines
compared to the baseline category. The DRG weight of the product lines over time has been
estimated, in order to check wether it is observed a decline of the DRG weight for these two
product lines (the Neurology and the Orthopedics). However, it seems that these two product
lines retain a steady level of DRG weight over time in contrast to the DRG weight of the
Cardiovascular and Medical-Surgical product lines which is declined over time (See Table
3.4, model M3). So, it looks that the reduction of the LOS for the Neurology and Orthopedics
has not affected the DRG weight of the hospitals. Finally, it has not been mentioned any
significant increase of the number of the short-stay cases (See Table 3.16, model M12).
Table 3.15: Regression of the Product-line and Time variables on
the transformed LOS, using LMM .
Model M11: E[g(LOSi j)] = b0i+b1iHospital+β0+β1Cardioi j+β2MedSuri j+
+β3Neuroi j+β4Oncologyi j+β5Orthoi j+β6Spinei j+β7Timei j+
+β8(Cardio∗Time)i j+β9(MedSur ∗Time)i j+β10(Neuro∗Time)i j+
+β11(Oncology∗Time)i j+β12(Ortho∗Time)i j+β13(Spine∗Time)i j
Model M11
Variable Estimate Std.error 95%CI p-value
Intercept 0.689 0.027 (0.634, 0.743) < 0.0001
Cardiovascular 0.101 0.03 (0.044, 0.16) 0.0005
Medical-Surgical 0.195 0.029 (0.14, 0.25) < 0.0001
Neurology 0.2 0.031 (0.139, 0.263) < 0.0001
Oncology 0.19 0.035 (0.13, 0.26) < 0.0001
Orthopedics 0.344 0.032 (0.28, 0.41) < 0.0001
Spine 0.138 0.036 (0.067, 0.209) 0.0005
Time(Quarters) 0.0135 0.0038 (0.006, 0.021) 0.0005
Cardiovascular*Time -0.002 0.004 (-0.001, 0.006) 0.618
Medical-Surgical*Time -0.0062 0.0039 (-0.014, 0.0016) 0.1119
Neurology*Time -0.0094 0.0045 (-0.018, -0.0005) 0.038
Oncology*Time -0.0018 0.0054 (-0.012, 0.008) 0.74
Orthopedics*Time -0.0133 0.0044 (-0.02,-0.004) 0.003
Spine*Time -0.004 0.0052 (-0.014, 0.006) 0.432
Additional estimations
Varible Estimate Std.error 95%CI p-value
β7+β8 0.0115 0.0014 (0.00865, 0.01434) < 0.0001
β7+β9 0.0073 0.0011 (0.00526, 0.00938) < 0.0001
Type 3 test of Fixed effects
Varible X2 p-value
Productline 216.14 < 0.0001
Time*Productline 23.97 0.0005
25
Table 3.16: Logistic regression of the LOS (dichotomous)5 on time and hospitals
(interaction term included), using GLMM. Correlation structure AR(1).
Model M126 : log[Pr[g(LOS)i j=1]Pr[g(LOS)i j=0] ] = β0+β1H1i j+β2H2i j+
+β3H3i j+β4Timei j+β5(TimeH1)i j+β6(TimeH2)i j+β7(TimeH3)i j
Model M12
Variable Estimate Std.error 95%CI p-value
Intercept -0.55 0.11 (-0.765, -0.3412) < 0.0001
H2 -0.0227 0.0128 (-0.275, 0.229) 0.86
H3 0.1628 0.148 (-0.128, 0.454) 0.273
H4 0.549 0.15 (0.241, 0.858) 0.0005
Time (Quarters) -0.0143 0.009 (-0.0315, 0.0029) 0.1032
Time*H2 -0.011 0.012 (-0.0345, 0.0128) 0.368
Time*H3 -0.0035 0.017 (-0.0383, 0.0312) 0.841
Time*H4 -0.022 0.012 (-0.046, 0.0018) 0.069
Additional estimations
Variable Estimate Std.error 95%CI p-value
β4+β5 -0.025 0.0082 (-0.0414, -0.0089) 0.0025
β4+β6 -0.0178 0.0154 (-0.048, 0.0124) 0.247
β4+β7 -0.0367 0.0086 (-0.0536, -0.0198) < 0.0001
Score statistics for Type 3 test (GEE Analysis)
Varible X2 p-value
Hospitals 12.18 0.0068
Time*Hospitals 3.55 0.3143
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Chapter 4
Discussion
DRG is a case-classification system developed in 1970 in Yale. The goal of this system is to group
together medically similar cases, which estimated to require, on average, similar hospital resources.
The higher the DRG the higher the CMI and thus, the higher the hospital’s reimbursements.
The changes in the CMI could be the result of several factors. For this thesis, three factors have been
checked for their relatedness to the DRG weights (and as a result to the CMI). These three factors
are the changes in the number of the several productlines (7 product lines in total), the surgical cases
and the length of stay.
The data was collected for each quartile through the years 2011-2013, from 4 different hospitals in
the state of Indiana. The results were obtained by applying linear mixed models to account for the
correlation between the observations.
Overall, a DRG reduction of the Cardiovascular and Medical-Surgical product lines was obtained for
the data combining all four hospitals. However, it seems that the decline in the Cardiovascular DRG
could be the result of the significant decline of that product line in the H4 hospital specifically (which
has the larger number of Cardiovascular cases compered to the rest of the hospitals). No significant
change of the DRG over time was observed for the rest of the productlines. After studying the
changes of the number of the Surgical cases and the length of stay (we were interested in the decline
of the LOS and in the increase of the short-stay cases), no significant results were found.
As a conclusion, the three hospitals H1, H2, H3 show a decline in the DRG over time, which is
not statistically significant. The only significant DRG decline is for the H4 hospital.The overall CV
DRG also shows a decline, probably due to the the DRG decline of CV productline observed in the
H4 hospital. There was no obvious effect of the Medical/Surgial volume, nor of the LOS. Further
study of the CV-productline in the H4 hospital is needed by specialists. In addition, changes in the
DRG that have been detected by the specific analysis could also be the result of other factors that
affect the CMI/DRG, like the changes in the coding system, the documentation etc. Unfortunately
these factors cannot be tested based on the given data.
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